HBOT Conversations:
Dr. Paul Harch & 8,101 Genes
He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.
This episode on 8,101 genes is the eighth in a nine episode series that will be released weekly with Dr. Harch.
Watch the Podcast
In episode 8 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch, about aging and the 8,101 genes HBOT affects.
di Girolamo starts this conversation with Dr. Harch bringing up the 8,101 genes that are activated by Hyperbaric Oxygen Therapy. The discussion leads to talk of Big Pharma, telomeres, reparative gene process, patents, and successful business models for HBOT clinics.
Dr. Harch explains that Hyperbaric Oxygen Therapy affects 8,101 of our genes, and it’s doing so on a different level for the ones that are overactive and abnormal in the disease process. He speaks of a 2004 lecture he gave to A4M about the effects of HBOT on longevity; and asks, “Where is senescence and aging based?”, answering with, “It’s in our DNA”. Dr. Harch dives in to how HBOT turns on our genes to grow new tissue and stimulates cellular repair and regeneration. di Girolamo agrees and brings up a different past lecture from Dr. Harch where Harch referred to Hyperbaric Oxygen Therapy as the ‘Fountain of Youth‘.
This series ends with Dr. Harch discussing a Buffalo VA study, and how the study subjects (comprised of older veterans) literally came alive and started propositioning nurses after Hyperbaric Oxygen Therapy treatments. He explained this is why no follow-up study was ever done because they weren’t expecting such and didn’t know what to do. Makes sense…. studies have shown success in HBOT treating erectile dysfunction.
If you are searching for the Fountain of Youth and ready to activate 8,101 genes in your body —- find a Hyperbaric Oxygen Therapy clinic near you.
Subscribe Now, It’s Free!
Guest
Dr. Paul G. Harch, MD
Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.
Harch HBOT – Hyperbaric Oxygen Therapy Clinic
5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/
Recent HBOT News
Clinical Trial – Low Dose Spinal Anesthesia in Cesarean Surgery
Anesthesia for cesarean section requires special importance because it may affect both mother
and the baby. To avoid maternal hypotension related to spinal anesthesia must be the primary
objective during anesthesia. Even though many factors influence sensory nerve block for
surgical anesthesia, local anesthetic dose is the main determinant. Another factor that
influence the sensory nerve block is the obesity related to pregnancy. Due to the enlargement
of epidural venous plexus related to pregnancy, the subarachnoid and epidural space reduces,
so the local anesthetic requirement also reduces. Many investigators recommend lower dose of
local anesthetic in obese patients due to reduced requirement There are many studies about
dose regimens for cesarean anesthesia, but ideal dose have not been found. Investigators have
designed this study to see the effects of conventional dose (10 mg bupivacaine) vs. low dose
plus fentanyl (7,5 mg bupivacaine+25 mcg fentanyl) in obese and normal weight pregnant for
cesarean section. The hypothesis was: the low dose regimen provides surgical anesthesia in
obese patients while avoiding maternal hypotension.
A case of acute onset postoperative gas gangrene caused by Clostridium perfringens.
Abstract: Gas gangrene is a necrotic infection of soft tissue associated with high mortality rates. We report a case of postoperative gas gangrene with very acute onset and rapid progression of symptoms. To our knowledge, this case is the most acute onset of...
Clinical Trial – Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines
In this small pilot study, participants (patients and healthy volunteers) will have blood
drawn before and after the study intervention (hyperbaric chamber session or normal pressure
oxygen breathing. This blood will be analyzed for neutrophil oxidative burst and cytokine
analysis.